Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia - 2 Minute Medicine
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia 2 Minute Medicine
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia 2 Minute Medicine
Endometrial cancer - Symptoms and causes Mayo Clinic
GLP-1 Combination Reduced Endometrial Cancer Risk by 66%, Study Finds Pharmacy Times
Combining GLP-1 drugs with hormones may lower uterine cancer risk Medical Xpress
GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk Medscape
Endometrial cancer is rising among older women, minorities 6abc Philadelphia
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... Medical Dialogues
Is Bleeding After Menopause Always Cancer? HealthCentral
Uterine Cancer: Unveiling the Unseen & Urgent Need AstraZeneca
Endometrial Cancer Cure Rate: What Patients Need to Know in 2025 Oncodaily
More Good News for GLP-1 Agonists and Cancer Risk MedPage Today
Tamoxifen induces PI3K activation in uterine cancer Nature
Can PCOS lead to uterine cancer? Roswell Park Comprehensive Cancer Center
Evaluating Radiotheranostic Targets for Endometrial Cancer Journal of Nuclear Medicine
A STEM educator battles rare endometrial cancer UT Physicians
KU Cancer Center evaluating progestin use to treat endometrial cancer University of Kansas Medical Center
First Early Endometrial Cancer Detection Test Launched by Gnosis Inside Precision Medicine
Endometrial Cancer Clinical Updates Consultant360
DCS-NET: a multi-task model for uterine ROI detection and automatic staging of early endometrial cancer in MRI Nature
Endometrial Cancer: 5 Things to Know Medscape
UNM Cancer Center Physician-Scientist Awarded $12.9M Grant to Study Endometrial Cancer UNM HSC Newsroom
The role of the microbiome in endometrial carcinoma: Pathogenesis, biomarkers, and therapeutic prospects Wiley
Alicia Latham, MD, MS, on Using ctDNA to Detect Endometrial Cancer The ASCO Post
Emerging drug delivery approach using nanomaterials for the treatment of endometrial cancer Frontiers
How One Patient’s Story Illustrates Advances in Understanding Endometrial Cancer Medscape
Dana-Farber Research Uncovers Potential Targeted Therapy for Endometrial Cancer Dana-Farber Cancer Institute
New Emory research uses AI to find pathologic and genetic basis for worse outcome of endometrial cancer in Black women Emory University
Are brain metastases a special issue in POLE-mutated endometrial cancer? a case report series Frontiers
Targeting the Untargeted: A Call to Action for p53-Abnormal Endometrial Cancers ASCO Daily News
Acta Obstetricia et Gynecologica Scandinavica | NFOG Women's Health Journal | Wiley Online Library Wiley
How Tamoxifen Raises Uterine Cancer Risk—and a Path to Prevention Inside Precision Medicine
Computational image and molecular analysis reveal unique prognostic features of immune architecture in African Versus European American women with endometrial cancer | npj Precision Oncology Nature
Omentectomy for apparent early-stage uterine serous carcinoma: a large retrospective cohort study Frontiers
Finding Our Way Forward: Navigating the Emotional Journey of Endometrial Cancer Katie Couric Media
Laparoscopic Surgery in a Patient With Endometrial Cancer After Laparoscopic Sacrocolpopexy Cureus
Sylvester Comprehensive Cancer Center Launches Clinical Trial on Fasting for Endometrial Cancer Miller School of Medicine News
5 Subtle Signs of Endometrial Cancer You Should Never Ignore, According to Doctors Prevention
9 Endometrial Cancer Treatment Side Effects, and How to Manage Them Everyday Health
Endometrial Cancer and Body Image: How to Cope and Rebuild Confidence Everyday Health
Dark and Lovely Lawsuit Motley Rice